Skip to menu Skip to content Skip to footer
Dr Benedict Lum
Dr

Benedict Lum

Email: 

Overview

Background

Over 5 years of experience in translational biomedical research, specialising in monoclonal antibody-based therapies, immuno-oncology, target discovery and theranostics in cancer. My main research focus is on targeted cancer therapies, understanding how target receptor endocytosis affects antibody drug conjugate (ADC) and radioligand therapy delivery, immune-mediated ADCC, and how combination therapies with immune checkpoint inhibitors can potentially improve therapeutic outcomes for patients.

Availability

Dr Benedict Lum is:
Not available for supervision

Qualifications

  • Bachelor (Honours) of Biomedical Sciences, The University of Queensland
  • Doctor of Philosophy of Biomedical Science, The University of Queensland

Works

Search Professor Benedict Lum’s works on UQ eSpace

7 works between 2020 and 2024

1 - 7 of 7 works

2024

Journal Article

Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors

Muraro, Elena, Montico, Barbara, Lum, Benedict, Colizzi, Francesca, Giurato, Giorgio, Salvati, Annamaria, Guerrieri, Roberto, Rizzo, Aurora, Comaro, Elisa, Canzonieri, Vincenzo, Anichini, Andrea, Del Vecchio, Michele, Mortarini, Roberta, Milione, Massimo, Weisz, Alessandro, Pizzichetta, Maria Antonietta, Simpson, Fiona, Dolcetti, Riccardo, Fratta, Elisabetta and Sigalotti, Luca (2024). Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors. Frontiers in Immunology, 15 1336566. doi: 10.3389/fimmu.2024.1336566

Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors

2023

Other Outputs

Improving monoclonal antibody therapies with temporary and reversible endocytosis inhibition

Lum, Benedict (2023). Improving monoclonal antibody therapies with temporary and reversible endocytosis inhibition. PhD Thesis, Frazer Institute, The University of Queensland. doi: 10.14264/12d5eba

Improving monoclonal antibody therapies with temporary and reversible endocytosis inhibition

2023

Journal Article

Endocytosis in cancer and cancer therapy

Banushi, Blerida, Joseph, Shannon R., Lum, Benedict, Lee, Jason J. and Simpson, Fiona (2023). Endocytosis in cancer and cancer therapy. Nature Reviews Cancer, 23 (7), 1-24. doi: 10.1038/s41568-023-00574-6

Endocytosis in cancer and cancer therapy

2021

Journal Article

Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy

Nightingale, James, Lum, Benedict, Ladwa, Rahul, Simpson, Fiona and Panizza, Benedict (2021). Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy. Biochimica et Biophysica Acta, 1875 (2) 188523, 1-9. doi: 10.1016/j.bbcan.2021.188523

Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy

2021

Journal Article

Adenoid cystic carcinoma: a review of clinical features, treatment targets and advancement in improving the immune response to monoclonal antibody therapy

Nightingale, James, Lum, Benedict, Ladwa, Rahul, Simpson, Fiona and Panizza, Benedict (2021). Adenoid cystic carcinoma: a review of clinical features, treatment targets and advancement in improving the immune response to monoclonal antibody therapy. Biochimica et Biophysica Acta. Reviews on Cancer, 1875 (2) 188523, 1-9. doi: 10.1016/j.bbcan.2021.188523

Adenoid cystic carcinoma: a review of clinical features, treatment targets and advancement in improving the immune response to monoclonal antibody therapy

2020

Journal Article

Antibody/ligand-target receptor internalization assay protocol using fresh human or murine tumor ex vivo samples

Joseph, Shannon R., Lum, Benedict, Banushi, Blerida, Barry, Rachael, Panizza, Benedict, Walpole, Euan and Simpson, Fiona (2020). Antibody/ligand-target receptor internalization assay protocol using fresh human or murine tumor ex vivo samples. STAR Protocols, 1 (2) 100087, 100087. doi: 10.1016/j.xpro.2020.100087

Antibody/ligand-target receptor internalization assay protocol using fresh human or murine tumor ex vivo samples

2020

Journal Article

Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies

Chew, Hui Yi, De Lima, Priscila O., Gonzalez Cruz, Jazmina L., Banushi, Blerida, Echejoh, Godwins, Hu, Lingbo, Joseph, Shannon R., Lum, Benedict, Rae, James, O'Donnell, Jake S., Merida de Long, Lilia, Okano, Satomi, King, Brigid, Barry, Rachael, Moi, Davide, Mazzieri, Roberta, Thomas, Ranjeny, Souza-Fonseca-Guimaraes, Fernando, Foote, Matthew, McCluskey, Adam, Robinson, Phillip J., Frazer, Ian H., Saunders, Nicholas A., Parton, Robert G., Dolcetti, Riccardo, Cuff, Katharine, Martin, Jennifer H., Panizza, Benedict, Walpole, Euan ... Simpson, Fiona (2020). Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies. Cell, 180 (5), 895-914.e27. doi: 10.1016/j.cell.2020.02.019

Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies

Media

Enquiries

For media enquiries about Dr Benedict Lum's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au